Operating Segments (Tables)

3 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three months ended December 31,
(Dollars in thousands)	2013			2012
Revenue:
Medical Device	$	10,549		$	10,531
In Vitro Diagnostics		3,334			3,320
Total revenue	$	13,883		$	13,851
Operating income:
Medical Device	$	5,328		$	5,840
In Vitro Diagnostics		671			751
Total segment operating income		5,999			6,591
Corporate		(1,670	)		(1,714	)
Total operating income	$	4,329		$	4,877
Depreciation and amortization:
Medical Device	$	294		$	317
In Vitro Diagnostics		214			215
Corporate		189			190
Total depreciation and amortization	$	697		$	722